FIBCD1 and colon adenocarcinoma: Utilizing the Gene Expression Profiling Interactive Analysis (GEPIA) platform (www.gepia.cancer-pku.cn) (22), we assessed the differential expression of FIBCD1 in colon adenocarcinoma (COAD) by analyzing tumor samples (n=274) from The Cancer Genome Atlas (TCGA) and comparing them to normal samples from both TCGA and Genotype-Tissue Expression (GTEx) datasets (n=349).